# The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients

> **NCT06723665** · NA · ENROLLING_BY_INVITATION · sponsor: **Affiliated Hospital of Jiangnan University** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 18F-PSMA-1007
- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT06723665
- **Lead sponsor:** Affiliated Hospital of Jiangnan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-01-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06723665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06723665, "The Exploration of 18F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06723665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*